BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20117169)

  • 21. Role of the high mobility group A proteins in the regulation of pituitary cell cycle.
    Fedele M; Fusco A
    J Mol Endocrinol; 2010 Jun; 44(6):309-18. PubMed ID: 20219853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
    Huang SM; Schönthal AH; Stallcup MR
    Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
    Carneiro C; Jiao MS; Hu M; Shaffer D; Park M; Pandolfi PP; Cordon-Cardo C; Koff A
    Oncogene; 2003 Jan; 22(3):361-9. PubMed ID: 12545157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new coactivator function for Zac1's C2H2 zinc finger DNA-binding domain in selectively controlling PCAF activity.
    Hoffmann A; Spengler D
    Mol Cell Biol; 2008 Oct; 28(19):6078-93. PubMed ID: 18663001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multitasking C2H2 zinc fingers link Zac DNA binding to coordinated regulation of p300-histone acetyltransferase activity.
    Hoffmann A; Barz T; Spengler D
    Mol Cell Biol; 2006 Jul; 26(14):5544-57. PubMed ID: 16809786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
    Abdollahi A; Bao R; Hamilton TC
    Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
    Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
    Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.
    Kumar R; Manning J; Spendlove HE; Kremmidiotis G; McKirdy R; Lee J; Millband DN; Cheney KM; Stampfer MR; Dwivedi PP; Morris HA; Callen DF
    Mol Cancer Res; 2006 Sep; 4(9):655-65. PubMed ID: 16966434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional domains of the TGF-beta-inducible transcription factor Tieg3 and detection of two putative nuclear localization signals within the zinc finger DNA-binding domain.
    Spittau B; Wang Z; Boinska D; Krieglstein K
    J Cell Biochem; 2007 Jun; 101(3):712-22. PubMed ID: 17252542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
    Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
    Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and consequences of galectin-3 expression in pituitary tumors.
    Righi A; Jin L; Zhang S; Stilling G; Scheithauer BW; Kovacs K; Lloyd RV
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):8-14. PubMed ID: 20451577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.
    Ait-Si-Ali S; Polesskaya A; Filleur S; Ferreira R; Duquet A; Robin P; Vervish A; Trouche D; Cabon F; Harel-Bellan A
    Oncogene; 2000 May; 19(20):2430-7. PubMed ID: 10828885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation.
    Barz T; Hoffmann A; Panhuysen M; Spengler D
    Cancer Res; 2006 Dec; 66(24):11975-82. PubMed ID: 17178896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
    Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
    Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclins and their related proteins in pituitary tumourigenesis.
    Muşat M; Morris DG; Korbonits M; Grossman AB
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):25-9. PubMed ID: 20347931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin remodeling and histone modifications in pituitary tumors.
    Tateno T; Zhu X; Asa SL; Ezzat S
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis.
    Su HC; Wu SC; Yen LC; Chiao LK; Wang JK; Chiu YL; Ho CL; Huang SM
    Sci Rep; 2020 Jul; 10(1):11837. PubMed ID: 32678267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cells.
    Lanaspa MA; Andres-Hernando A; Rivard CJ; Dai Y; Li N; Berl T
    J Biol Chem; 2009 Jul; 284(30):19974-81. PubMed ID: 19423711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.